<p>미국 FDA, REGEN-COV®(카시리비맙 및 임데비맙) COVID-19 치료 및 예방을 위한 우선 검토 대상 선정 - 1보 <br>- 리젠은 세계최초 코로나 치료제 항체 치료제 <br>FDA Accepts REGEN-COV® (casirivimab and imdevimab) for Priority Review for Treatment and Prophylaxis of COVID-19 <br><br>****  미래에셋벤처투자 ( 100790 ) <br>미래에셋벤처, 리네제론 세계최초 코로나 치료제 출시 소식  급등 <br><br><a href="https://www.wwnytv.com/prnewswire/2021/10/14/fda-accepts-regen-cov-casirivimab-imdevimab-priority-review-treatment-prophylaxis-covid-19/" target="_blank" class="ke-link">https://www.wwnytv.com/prnewswire/2021/10/14/fda-accepts-regen-cov-casirivimab-imdevimab-priority-review-treatment-prophylaxis-covid-19/</a> <br><br><br><a href="https://www.fnnews.com/news/202012031351469433" target="_blank" class="ke-link">https://www.fnnews.com/news/202012031351469433</a><br><br><br><span data-ke-size="size14">*** 본 정보는 투자 참고용 자료로서 그 정확성이나 완전성을 보장할 수 없으며, 어떠한 경우에도 법적 책임소재에 대한 증빙자료로 사용될 수 없습니다.</span></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="FDA Accepts REGEN-COV® (casirivimab and imdevimab) for Priority Review for Treatment and Prophylaxis of COVID-19" data-og-description="European Medicines Agency also announced earlier this week it would review Marketing Authorization Application for the antibody cocktail" data-og-host="www.wwnytv.com" data-og-source-url="https://www.wwnytv.com/prnewswire/2021/10/14/fda-accepts-regen-cov-casirivimab-imdevimab-priority-review-treatment-prophylaxis-covid-19/" data-og-url="https://www.wwnytv.com/prnewswire/2021/10/14/fda-accepts-regen-cov-casirivimab-imdevimab-priority-review-treatment-prophylaxis-covid-19/" data-og-image=""><a href="https://www.wwnytv.com/prnewswire/2021/10/14/fda-accepts-regen-cov-casirivimab-imdevimab-priority-review-treatment-prophylaxis-covid-19/" target="_blank" data-source-url="https://www.wwnytv.com/prnewswire/2021/10/14/fda-accepts-regen-cov-casirivimab-imdevimab-priority-review-treatment-prophylaxis-covid-19/"><div class="og-image" style="background-image:url()"></div><div class="og-text"><p class="og-title">FDA Accepts REGEN-COV® (casirivimab and imdevimab) for Priority Review for Treatment and Prophylaxis of COVID-19</p><p class="og-desc">European Medicines Agency also announced earlier this week it would review Marketing Authorization Application for the antibody cocktail</p><p class="og-host">www.wwnytv.com</p></div></a></div><div class="figure-img" data-ke-type="image" data-ke-style="alignLeft" data-ke-mobilestyle="widthOrigin" data-link="https://cafe.daum.net/stockwang/As9F/3000" data-link-newwindow="_self"><a href="https://cafe.daum.net/stockwang/As9F/3000" target="_top" class="ke-link"><img src="https://t1.daumcdn.net/cfile/cafe/99BD19405F90343305" data-img-src="https://t1.daumcdn.net/cfile/cafe/99BD19405F90343305" data-origin-width="774" data-origin-height="95"></a></div><p> </p>
<!-- -->
